BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Abdou AG. CD10 expression in tumour and stromal cells of bladder carcinoma: an association with bilharziasis. APMIS 2007;115:1206-18. [PMID: 18092952 DOI: 10.1111/j.1600-0643.2007.00645.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Gürel D, Kargı A, Karaman I, Önen A, Ünlü M. CD10 Expression in Epithelial and Stromal Cells of Non-small Cell Lung Carcinoma (NSCLC): A Clinic and Pathologic Correlation. Pathol Oncol Res 2012;18:153-60. [DOI: 10.1007/s12253-011-9421-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
2 Oba J, Nakahara T, Hayashida S, Kido M, Xie L, Takahara M, Uchi H, Miyazaki S, Abe T, Hagihara A, Moroi Y, Furue M. Expression of CD10 predicts tumor progression and unfavorable prognosis in malignant melanoma. Journal of the American Academy of Dermatology 2011;65:1152-60. [DOI: 10.1016/j.jaad.2010.10.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
3 Ahmed AR, Muhammad EM. E-cadherin and CD10 expression in atypical hyperplastic and malignant endometrial lesions. J Egypt Natl Canc Inst 2014;26:211-7. [PMID: 25282623 DOI: 10.1016/j.jnci.2014.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
4 Bahadir B, Behzatoglu K, Bektas S, Bozkurt ER, Ozdamar SO. CD10 expression in urothelial carcinoma of the bladder. Diagn Pathol 2009;4:38. [PMID: 19917108 DOI: 10.1186/1746-1596-4-38] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
5 Council L, Hameed O. Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma. Mod Pathol. 2009;22:639-650. [PMID: 19252475 DOI: 10.1038/modpathol.2009.9] [Cited by in Crossref: 61] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
6 Miyamoto T, Ishii K, Asaka R, Suzuki A, Takatsu A, Kashima H, Shiozawa T. Immunohistochemical expression of keratan sulfate: a possible diagnostic marker for carcinomas of the female genital tract. J Clin Pathol 2011;64:1058-63. [PMID: 21836037 DOI: 10.1136/jclinpath-2011-200231] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
7 Kim H, Kim GY, Kim YW, Park Y, Song J, Lim S. Stromal CD10 expression and relationship to the E-cadherin/β-catenin complex in breast carcinoma: CD10/E-cadherin/β-catenin in IDC. Histopathology 2010;56:708-19. [DOI: 10.1111/j.1365-2559.2010.03534.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
8 Teyssier VR, Simard JM, Dornan MH, Tournoux F, DaSilva JN. Radiosynthesis of the 11 C-methyl derivative of LBQ657 for PET investigation of the neprilysin inhibitor sacubitril. J Labelled Comp Radiopharm 2020;63:65-71. [PMID: 31912556 DOI: 10.1002/jlcr.3817] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Nikoo S, Ebtekar M, Jeddi-Tehrani M, Shervin A, Bozorgmehr M, Vafaei S, Kazemnejad S, Zarnani AH. Menstrual blood-derived stromal stem cells from women with and without endometriosis reveal different phenotypic and functional characteristics. Mol Hum Reprod 2014;20:905-18. [PMID: 24939730 DOI: 10.1093/molehr/gau044] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
10 Schramm HM. Should EMT of Cancer Cells Be Understood as Epithelial-Myeloid Transition? J Cancer. 2014;5:125-132. [PMID: 24494030 DOI: 10.7150/jca.8242] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
11 Mohammed AS, Ali HH, Qasim BJ, Chaloob MK. CD10 and CA19.9 immunohistochemical expression in transitional cell carcinoma of the urinary bladder. Urol Ann 2013;5:81-5. [PMID: 23798862 DOI: 10.4103/0974-7796.110002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
12 Oba J, Nakahara T, Hashimoto-Hachiya A, Liu M, Abe T, Hagihara A, Yokomizo T, Furue M. CD10-Equipped Melanoma Cells Acquire Highly Potent Tumorigenic Activity: A Plausible Explanation of Their Significance for a Poor Prognosis. PLoS One 2016;11:e0149285. [PMID: 26881775 DOI: 10.1371/journal.pone.0149285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
13 Jang TJ. CD10 Is Again Expressed at a Certain Stage during the Neoplastic Process of Bladder Transitional Cell Carcinomas. Cancer Res Treat 2012;44:262-6. [PMID: 23341790 DOI: 10.4143/crt.2012.44.4.262] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
14 Maguer-satta V, Besançon R, Bachelard-cascales E. Concise Review: Neutral Endopeptidase (CD10): A Multifaceted Environment Actor in Stem Cells, Physiological Mechanisms, and Cancer. STEM CELLS 2011;29:389-96. [DOI: 10.1002/stem.592] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 9.5] [Reference Citation Analysis]
15 Hussien MT, Helmy E, Elsaba TM, Elkady A, Alrefai H, Hetta HF. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma. Asian Pac J Cancer Prev 2020;21:1573-83. [PMID: 32592351 DOI: 10.31557/APJCP.2020.21.6.1573] [Reference Citation Analysis]
16 Li M, Wang L, Zhan Y, Zeng T, Zhang X, Guan XY, Li Y. Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis. Am J Pathol 2019;189:1462-72. [PMID: 31054987 DOI: 10.1016/j.ajpath.2019.04.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]